Opioid and stimulant co-prescribing does not equate to a co-epidemic.
作者信息
Xu Kevin Young, Grucza Richard A, Tardelli Vitor Soares, Quinn Patrick D, Scherrer Jeffrey F
机构信息
Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Advanced HEAlth Data (AHEAD) Institute, Saint Louis University School of Medicine, St. Louis, MO, USA.
出版信息
Lancet Reg Health Am. 2025 Apr 17;45:101093. doi: 10.1016/j.lana.2025.101093. eCollection 2025 May.
Abstract
摘要
相似文献
1
Opioid and stimulant co-prescribing does not equate to a co-epidemic.阿片类药物与兴奋剂联合处方并不等同于两种药物同时流行。
Lancet Reg Health Am. 2025 Apr 17;45:101093. doi: 10.1016/j.lana.2025.101093. eCollection 2025 May.
2
Changes in Surgical Opioid Prescribing and Patient-Reported Outcomes After Implementation of an Insurer Opioid Prescribing Limit.实施保险公司阿片类药物处方限制后外科手术阿片类药物处方及患者报告结局的变化
JAMA Health Forum. 2023 Oct 6;4(10):e233541. doi: 10.1001/jamahealthforum.2023.3541.
3
Postpartum Opioid Prescribing in Patients with Opioid Use Prior to Birth.分娩前使用阿片类药物的患者产后阿片类药物处方
Am J Perinatol. 2024 May;41(S 01):e1459-e1462. doi: 10.1055/s-0043-1767816. Epub 2023 Apr 10.
4
Does Preoperative Pharmacogenomic Testing of Patients Undergoing TKA Improve Postoperative Pain? A Randomized Trial.接受 TKA 的患者行术前药物基因组学检测是否能改善术后疼痛？一项随机试验。
Clin Orthop Relat Res. 2024 Feb 1;482(2):291-300. doi: 10.1097/CORR.0000000000002767. Epub 2023 Aug 18.
5
Excess Opioid Medication and Variation in Prescribing Patterns Following Common Breast Plastic Surgeries.常见乳房整形手术后阿片类药物使用过量及处方模式差异
Plast Surg (Oakv). 2024 Nov;32(4):606-613. doi: 10.1177/22925503231172789. Epub 2023 May 26.
6
Impacts of State-Level Opioid Review Programs on Injured Workers and Their Health Care Providers: A Qualitative Study in Washington and Ohio.州级阿片类药物审查项目对受伤工人及其医疗保健提供者的影响：华盛顿州和俄亥俄州的定性研究。
Milbank Q. 2024 Sep;102(3):605-631. doi: 10.1111/1468-0009.12705. Epub 2024 Jun 11.
7
Multi-institutional retrospective study on opioid prescribing patterns of oral and maxillofacial surgeons.口腔颌面外科医生阿片类药物处方模式的多机构回顾性研究
J Am Dent Assoc. 2025 Feb;156(2):124-132.e1. doi: 10.1016/j.adaj.2024.11.009. Epub 2025 Jan 15.
8
Interventions to Reduce Inpatient and Discharge Opioid Prescribing for Postpartum Patients: A Systematic Review.干预措施以减少产后患者的住院和出院阿片类药物处方：系统评价。
J Midwifery Womens Health. 2023 Mar;68(2):187-204. doi: 10.1111/jmwh.13475. Epub 2023 Feb 21.
9
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.兴奋剂和非兴奋剂药物治疗注意缺陷多动障碍和癫痫患者。
Cochrane Database Syst Rev. 2022 Jul 13;7(7):CD013136. doi: 10.1002/14651858.CD013136.pub2.
10
5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Randomized Clinical Trial Protocol.腹部癌症手术后出院阿片类药物处方的5倍乘数法与三级模型对比：随机临床试验方案
Adv Cancer Educ Qual Improv. 2025;1(1). doi: 10.52519/aceqi.25.1.1.a19.
本文引用的文献
1
Polysubstance Use Is Not Synonymous With Poly Substance Use Disorder.多种物质使用并非等同于多种物质使用障碍。
Am J Public Health. 2025 May;115(5):646-648. doi: 10.2105/AJPH.2025.308070.
2
Polysubstance Use Profiles Among the General Adult Population, United States, 2022.2022年美国普通成年人群中的多物质使用情况
Am J Public Health. 2025 May;115(5):747-757. doi: 10.2105/AJPH.2024.307979. Epub 2025 Mar 20.
3
The recent trend of twin epidemic in the United States: a 10-year longitudinal cohort study of co-prescriptions of opioids and stimulants.美国近期的双重流行趋势：一项关于阿片类药物和兴奋剂联合处方的10年纵向队列研究。
Lancet Reg Health Am. 2025 Feb 17;44:101030. doi: 10.1016/j.lana.2025.101030. eCollection 2025 Apr.
4
Trends in Attention-Deficit Hyperactivity Disorder Diagnosis and Pharmacotherapy Among Adults With Opioid Use Disorder.阿片类物质使用障碍成人患者注意缺陷多动障碍的诊断和药物治疗趋势。
Psychiatr Serv. 2024 Mar 1;75(3):214-220. doi: 10.1176/appi.ps.20220400. Epub 2023 Oct 4.
5
Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk.阿片类药物使用障碍和共患精神兴奋剂使用障碍患者中处方苯丙胺开始使用丁丙诺啡：治疗保留和过量风险分析。
BMJ Ment Health. 2023 Jul;26(1). doi: 10.1136/bmjment-2023-300728.
6
Association Between Stimulant Treatment and Substance Use Through Adolescence Into Early Adulthood.兴奋剂治疗与物质使用的关联：从青少年到成年早期。
JAMA Psychiatry. 2023 Sep 1;80(9):933-941. doi: 10.1001/jamapsychiatry.2023.2157.
7
Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder.长期阿片类药物治疗期间使用处方兴奋剂与阿片类药物使用障碍风险
Drug Alcohol Depend Rep. 2022 Nov 24;5:100122. doi: 10.1016/j.dadr.2022.100122. eCollection 2022 Dec.
8
Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder.阿片类药物使用障碍患者接受丁丙诺啡治疗时的兴奋剂处方和与药物相关的中毒风险分析。
JAMA Netw Open. 2022 May 2;5(5):e2211634. doi: 10.1001/jamanetworkopen.2022.11634.
9
Prevalence and Correlates of Prescription Stimulant Use, Misuse, Use Disorders, and Motivations for Misuse Among Adults in the United States.美国成年人处方兴奋剂使用、滥用、使用障碍的流行情况及滥用动机的相关因素。
Am J Psychiatry. 2018 Aug 1;175(8):741-755. doi: 10.1176/appi.ajp.2018.17091048. Epub 2018 Apr 16.
10
ADHD Medication and Substance-Related Problems.注意力缺陷多动障碍药物与物质相关问题
Am J Psychiatry. 2017 Sep 1;174(9):877-885. doi: 10.1176/appi.ajp.2017.16060686. Epub 2017 Jun 29.
Zotero 插件